Lebrikizumab Monotherapy for the Treatment of Moderate to Severe Atopic Dermatitis

Nikki Kimura; Punita Ponda

doi:10.1016/j.jaip.2023.06.042

Lebrikizumab Monotherapy for the Treatment of Moderate to Severe Atopic Dermatitis

Nikki Kimura
, Punita Ponda

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	2957-2960
Number of pages	4
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	11
Issue number	9
DOIs	https://doi.org/10.1016/j.jaip.2023.06.042
State	Published - Sep 2023
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy

Access to Document

10.1016/j.jaip.2023.06.042

Cite this

@article{e274bdd05f374e819d3c02525c6ec8de,

title = "Lebrikizumab Monotherapy for the Treatment of Moderate to Severe Atopic Dermatitis",

author = "Nikki Kimura and Punita Ponda",

year = "2023",

month = sep,

doi = "10.1016/j.jaip.2023.06.042",

language = "English (US)",

volume = "11",

pages = "2957--2960",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "9",

}

TY - JOUR

T1 - Lebrikizumab Monotherapy for the Treatment of Moderate to Severe Atopic Dermatitis

AU - Kimura, Nikki

AU - Ponda, Punita

PY - 2023/9

Y1 - 2023/9

UR - https://www.scopus.com/pages/publications/85169018316

UR - https://www.scopus.com/pages/publications/85169018316#tab=citedBy

U2 - 10.1016/j.jaip.2023.06.042

DO - 10.1016/j.jaip.2023.06.042

M3 - Article

C2 - 37684078

AN - SCOPUS:85169018316

SN - 2213-2198

VL - 11

SP - 2957

EP - 2960

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 9

ER -

Lebrikizumab Monotherapy for the Treatment of Moderate to Severe Atopic Dermatitis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this